BRISTOL MYERS SQUIBB
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1989-01-01
- Employees
- 30K
- Market Cap
- $97.5B
- Website
- https://www.bms.com/
A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664)
- Conditions
- Tumors
- First Posted Date
- 2007-02-15
- Last Posted Date
- 2009-01-22
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 4
- Registration Number
- NCT00435669
- Locations
- 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
- Conditions
- Systemic Lupus Erythematosus
- Interventions
- First Posted Date
- 2007-02-02
- Last Posted Date
- 2015-03-20
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 423
- Registration Number
- NCT00430677
- Locations
- 🇺🇸
Wallace Rheumatic Study Center, Los Angeles, California, United States
🇺🇸Northshore Lij Health System, Lake Success, New York, United States
🇺🇸Ok Medical Research Foundation, Oklahoma City, Oklahoma, United States
Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3)
- Conditions
- Deep Vein ThrombosisPulmonary Embolism
- Interventions
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2014-05-14
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 5407
- Registration Number
- NCT00423319
- Locations
- 🇺🇸
Shrock Orthopedic Research, Ft. Lauderdale, Florida, United States
🇺🇸Orthoarkansas, P.A., Little Rock, Arkansas, United States
🇺🇸Pab Clinical Research, Brandon, Florida, United States
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
- First Posted Date
- 2007-01-18
- Last Posted Date
- 2018-05-02
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 64
- Registration Number
- NCT00423891
- Locations
- 🇺🇸
Connecticut Children'S Medical Center, Hartford, Connecticut, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇺🇸Mount Sinai School Of Medicine, New York, New York, United States
A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
- First Posted Date
- 2007-01-09
- Last Posted Date
- 2012-01-18
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 50
- Registration Number
- NCT00420199
- Locations
- 🇬🇧
Local Institution, Leeds, North Yorkshire, United Kingdom
A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin
- First Posted Date
- 2007-01-09
- Last Posted Date
- 2016-09-30
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 37
- Registration Number
- NCT00420186
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
🇬🇧Local Institution, Manchester, Greater Manchester, United Kingdom
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
- Conditions
- Atrial FibrillationAtrial Flutter
- Interventions
- First Posted Date
- 2006-12-19
- Last Posted Date
- 2018-07-03
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 20976
- Registration Number
- NCT00412984
- Locations
- 🇺🇸
David Charles Mishkel, Md, Pa, Boca Raton, Florida, United States
🇺🇸Heart Care Center, P.C., East Syracuse, New York, United States
🇺🇸Elkhart Clinic, Llc, Elkhart, Indiana, United States
Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus
- Conditions
- Hepatitis B, Chronic
- Interventions
- First Posted Date
- 2006-12-12
- Last Posted Date
- 2013-11-21
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 629
- Registration Number
- NCT00410202
- Locations
- 🇺🇸
University Of Connecticut Health Center, Farmington, Connecticut, United States
🇹🇷Local Institution, Trabzon, Turkey
Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B
- Conditions
- Hepatitis B, Chronic
- Interventions
- First Posted Date
- 2006-12-12
- Last Posted Date
- 2013-03-15
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 669
- Registration Number
- NCT00410072
- Locations
- 🇺🇸
University Of Michigan Health System, Ann Arbor, Michigan, United States
🇺🇸Sergio E. Rojter, Los Angeles, California, United States
🇺🇸Tuan Nguyen, Md, San Diego, California, United States
A Study of Abatacept in Patients With Active Ulcerative Colitis
- Conditions
- Ulcerative Colitis
- Interventions
- First Posted Date
- 2006-12-12
- Last Posted Date
- 2015-03-24
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 591
- Registration Number
- NCT00410410
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Atlanta Gastroenterology Associates, Atlanta, Georgia, United States
🇺🇸Rush University Medical Center, Chicago, Illinois, United States